Search All News
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Parkinson’s patients and their families are increasingly turning to genetic testing to learn more about their disease or risk of passing it on. But testing is complex, and counseling is advised.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
A newly discovered protein tangle has been associated with multiple neurodegenerative diseases and may have a role in causing the diseases.
- January 31, 2019
Aerobic exercise is known to improve cognition in the elderly; a new Columbia study shows it’s good for adults as young as 20.
- January 22, 2019
A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
- December 28, 2018
Columbia neurologists and engineers are developing what would be the first wearable diagnostic device for traumatic brain injury.
- December 17, 2018
A new study shows how cellular “housekeeping” protects some neurons against the toxic proteins of Alzheimer’s disease and suggests new treatment possibilities.
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
- September 26, 2018
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.